Search

everythinglearnresearchcommunity

for

Search:↓

Genetic differences within ethnic groups may affect prostate cancer treatment effectiveness.

High testosterone to epitestosterone ratio in hair could predict male-pattern baldness.

Dutasteride protects dopamine neurons in Parkinson's mice, but Finasteride doesn't.

Dutasteride is safe and effective for treating hair loss, but may decrease libido.

Men with coeliac disease may have hormone imbalances that could affect sexual function, but these can improve with better gut health.

Mutations in the SRD5A3 gene cause a new type of glycosylation disorder by blocking the production of a molecule necessary for protein glycosylation.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

Male pattern baldness might have evolved to help protect against prostate cancer by increasing UV radiation on the scalp.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

New pregnane derivatives were more effective than finasteride at inhibiting a key enzyme for male pattern baldness.

The nutritional supplement improved hair quality and reduced hair loss.

Female pattern hair loss diagnosed by scalp appearance, treated with combined therapies and targeted approaches.

Advancements in male reproductive medicine are ongoing, but more research and improved treatments are needed in several areas.

Finasteride for hair loss may cause lasting sexual, genitourinary, mental, and anti-androgenic side effects in young men.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

Hormonal treatment is effective for women with acne not helped by usual treatments, especially if they have hormonal imbalances.

The document concludes that sex hormones and related compounds have various effects on health, with both potential benefits and risks.

The guide recommends specific methods for diagnosing PCOS and various treatments for its symptoms, while considering the health impacts on adolescents.

Blocking the androgen receptor in skin cells reduces their growth response to male hormones, suggesting a possible treatment for skin conditions linked to androgens.

Some breast cancer patients on hormone therapy experience hair loss, and treatments like certain topical inhibitors and supplements may help without harming their cancer prognosis.

Neuroactive steroids show promise for treating mental and neurological disorders by targeting GABA_A receptors.

Hormonal therapies are effective for managing hair and skin symptoms in women with PCOS.

About 7% to 15% of Iranian women have polycystic ovary syndrome, depending on the criteria used to diagnose it.

About 13% of women had idiopathic hirsutism and 8.5% had polycystic ovary syndrome in a group of Iranian women.

Excessive body hair in women can be caused by various conditions and treated with medication like Diane® 35 or androgen blockers.

Hormones, especially testosterone and DHT, are key for penis development and function, and testosterone therapy may help with erectile dysfunction in those with low levels.

Most American men experience hair loss by age 50, with limited effective treatments available and new options not expected soon.

5α-reductase inhibitors help shrink the prostate, improve urinary symptoms, and may reduce prostate cancer risk.

New liposome treatment successfully delivers CRISPR to deactivate a key enzyme in androgen-related disorders.

The review suggests that while many AKR1C3 inhibitors show promise for treating certain cancers, more research is needed to confirm their effectiveness in humans.